Twelve patients with primary and metastatic brain tumors were evaluated with [68Galethylene diaminetetraacetate (EDTA ) and positron computed to mography, Using a two-compartment tracer kinetic model, foward (K I ) and reverse (k 2 ) rate constants for molecular diffusion across the blood-brain barrier (BBB) were obtained and averaged 0,0029 ± 0,00 16 (mean ± SD) mllmin/g for K I and 0,03 10 ± 0,0 156 min-I for kz' Most tracer kinetic models are based on the assumption that tissue radioactivity contains no vascular component or require independent measures of cerebral blood volume (CBV) which are then subtracted from the mea sure tissue activity, The model in this work differs from that approach by assuming a vascular compartment in the A loss of integrity of the blood-brain barrier (BBB) increases its permeability to a variety of sub stances (Rapoport, 1976) and forms the presumed pathophysiological mechanism of contrast enhance ment on X-ray computed tomography (CT) scans and tracer uptake in )I-emitting isotope brain-im aging studies. However, it is difficult to quantify the degree of BBB disruption with these methods in physiologic units. Positron CT produces estimates of the local concentrations of administered iso topes. With appropriate tracer kinetic models for these concentration measurements, a variety of Abbreviations used: AlB, ex-aminobutyric acid; BBB, blood brain barrier; CBY, cerebral blood volume; CP Y, cerebral plasma volume; CT, computed tomography; EDTA, eth ylenediaminetetraacetate.
Summary: Twelve patients with primary and metastatic brain tumors were evaluated with [68Galethylene diaminetetraacetate (EDTA ) and positron computed to mography, Using a two-compartment tracer kinetic model, foward (K I ) and reverse (k 2 ) rate constants for molecular diffusion across the blood-brain barrier (BBB) were obtained and averaged 0,0029 ± 0,00 16 (mean ± SD) mllmin/g for K I and 0,03 10 ± 0,0 156 min-I for kz' Most tracer kinetic models are based on the assumption that tissue radioactivity contains no vascular component or require independent measures of cerebral blood volume (CBV) which are then subtracted from the mea sure tissue activity, The model in this work differs from that approach by assuming a vascular compartment in the A loss of integrity of the blood-brain barrier (BBB) increases its permeability to a variety of sub stances (Rapoport, 1976) and forms the presumed pathophysiological mechanism of contrast enhance ment on X-ray computed tomography (CT) scans and tracer uptake in )I-emitting isotope brain-im aging studies. However, it is difficult to quantify the degree of BBB disruption with these methods in physiologic units. Positron CT produces estimates of the local concentrations of administered iso topes. With appropriate tracer kinetic models for these concentration measurements, a variety of tissue kinetic data, This vascular parameter is estimated from sequential measurements of activity concentrations in regions with an intact BBB or from measurements of 68Ga concentrations in the plasma (the input function), Thus, this approach does not require the assumption of a zero vascular contribution, does not require a separate measurement of CBV, and uses the criteria of constrained estimation to provide estimates of the local CBV and mo lecular diffusion through the BBB, Estimates of the rel ative CBY of the lesions in four studies (three subjects) with [68GalEDTA correlated well with those obtained with the C I SO hemoglobin technique (correlation coeffi cient of 0,97), Key Words: Blood-brain barrier diffu sion-Brain tumors-[68GalEDTA -Kinetic analysis, physiological processes can be quantitatively de scribed in humans in vivo. This approach is analo gous to animal studies with quantitative autoradiog raphy (Phelps et aI. , 1982) . Yen et al. (1982) have evaluated changes in BBB permeability in human brain tumors with 8 2 Rb and positron CT. Phelps et al. (1978) and Ericson et al. (1981) have identified the presence of an altered BBB in human brain tumors with [68GaJethylenediaminetetraacetate (EDTA) and positron CT. However, quantitative es timates of BBB permeability alterations in human brain tumors expressed in terms of transfer con stants or capillary permeability surface area prod ucts measured with [68GaJEDTA have not, to our knowledge, been reported. In a preliminary study, Kessler et al. (1983) quantitatively measured BBB permeability using [68GaJEDTA and positron CT in rhesus monkeys following osmotic opening at the BBB. In an earlier autoradiographic study, Ohno et al. (1978) employed a two-compartment model of the BBB to quantitate its permeability to glycerol, mannitol, sucrose, and inulin in rats.
We have used generator-produced [68Ga]EDTA and positron CT with a two-compartment model to estimate the rate constants Kl (transfer constant or forward rate constant for diffusion across the BBB) and k2 (reverse diffusion) in human brain tumors.
The vascular space is also included in the model as an adjustable parameter. This permits estimations of the cerebral blood volume (CBV) of the lesions and eliminates the need for a specific vascular space correction of the tissue (image) data. The approach distinguishes this technique from other models in which the vascular space activity is ignored or as sumed to be insignificant. Comparisons of the CBV estimates obtained with this method and measured directly with C I SO were also performed.
MATERIALS AND METHODS

Mathematical model
[68GaJEDTA is a labeled molecule that does not cross cell membranes to any significant degree and is largely excluded from diffusing into the brain from the blood by an intact BBB. With alterations in the BBB, forward and reverse diffusion of [68GaJEDTA occurs across the BBB, although in the tissue compartment, 68Ga should remain in the extracellular space. The total amount of 68Ga ac tivity (Cj) in positron CT "tissue" measurements (re gions-of-interest activity concentration measurements) will be composed of activity in the extracellular space (Ce) and in the plasma space of the tissue. If Cc represents the concentration of 68Ga in a brain region with an in tact BBB, then the extracellular concentration of [68GaJEDTA (Ce) is (I) where Vr is a unitless weighting term that will equal the relative plasma volume of region i compared with region c. If regions i and c have the same image coordinates (i.e., they correspond to the same location in the brain), or if they are in different locations but have the same plasma volume, Vr equals I. If Cp is the 68Ga activity concentration in plasma itself, then the extracellular (Ce) and total (C) tissue concentrations of [68GaJEDTA are related by (2) where Va represents the absolute value of cerebral plasma volume (CP V) in units of ml/g when Cp is expressed in units of activity per ml. When expressing a mathematical relationship between tissue and blood data, as in Eq. 2, a calibration factor must be applied to the positron CT (Ce• C) or plasma (Cp) well counter data (Phelps et aI., 1979a) . This calibration factor corrects for different counting efficiencies of the tomograph and well counter.
After a bolus intravenous administration of the tracer, if Ce(t) and Cp(t) are the activity concentrations of 68Ga in the tissue extracellular space and plasma, respectively, as a function of time, then, assuming a two-compartment (plasma and tissue) distribution of the tracer: Vol. 4, No.4, 1984 (3)
where Kl and k 2 are first-order rate constants for forward and reverse diffusion across the BBB. Solving Eq. 3, as suming Ce(O) = 0, gives or I Ce(T) = e-k 2 T I ek 2 tK I Cp(t) dt o where * indicates the operation of convolution.
Substituting into Eqs. I and 2 results in and CJt) = K1e-k 2 t * CpU) + VrCc(t)
The use of serial measurements of Cj (t) (from regions with a disrupted BBB), Cc(t) (from regions with an intact BBB), Cp(t), and an iterative least-squares fitting routine of Eqs. 6 and 7 produces estimates of K I (ml/min/g), k 2 (min-I ), Vr (unitless), and Va (ml/g). The assumption of equal hematocrits in the test region i and the control (in tact BBB) region (' means that Vr also equals the relative CBV in the region. Because Va in Eq. 7 represents CP V, the regional CBV of region i (rCBV) is
where the central hematocrit (CHct) is �85% of the pe ripheral (measured) hematocrit (Hct) (Phelps et al., 1979h) .
Direct measurement of CBV Phelps et al. (l979h) validated a method for determining the regional CBV in units of mlllOO g with the inhalation of labeled carbon monoxide (CO) and external counting with positron CT. If C L i represents the activity concen tration of C150 in region i ("C was used in the original validation), Cb is the blood concentration (counts/min/ ml), and d is the density of brain tissue (1.04 g/cc), then
where the factor 0.85 corrects for the difference in pe ripheral and central hematocrits as described above and cal is the calibration term between the tomograph and well counter. The relative CBV in region i compared with region c is
[68GaJEDTA was obtained from a 68Ge_68Ga generator supplied by New England Nuclear. Eluates were peri odically tested for sterility and pyrogenicity. Patients were injected with 7-10 mCi i.v. In nontumor patients, the dose was limited to 7 mCi, but in those with docu mented high-grade astrocytomas or metastatic disease in the CNS, somewhat higher doses were used. These pa tients were ordinarily candidates for, or had already re ceived, radiation therapy, and the additional radiation burden from a higher dose of 68Ga was therefore negli gible.
Cl50 was used for the direct measurements of CBY. Carbon monoxide, labeled with 150 (half-life 2 min) was prepared by the staff of the UCLA Medical Cyclotron by bombarding nitrogen gas containing 1% oxygen with 9.3-Me V deuterons, and passing the target gas over activated charcoal at 950°C. The gas was pumped to a reservoir in the positron CT laboratory, where 300-ml aliquots were transferred to an inhalation apparatus for administration to the patient. Patients were given Cl50 from a bag con taining O2 and C150. The residual Cl50 was vented back into the bag and the subject returned to breathing room air. The normal administered dose was 20-40 mCi.
Positron CT procedures
{68CajEDTA studies. Simultaneously with the intrave nous administration of [68Ga]EDTA over � 1 min, posi tron CT scanning was begun in the medium resolution mode of a NeuroECAT tomograph (Hoffman et a!., 1983) . Three simultaneous images were obtained at levels par allel to the canthomeatal line. Scan levels were chosen after evaluation of an X-ray CT image to maximize the likelihood of imaging the lesions evident on the X-ray CT studies. The same levels were scanned repeatedly at pro gressively lengthening intervals for a total scan time of �2 h. The scanning sequence consisted of I-min scans for the first 5 min, 2-min scans for the next 10 min, 5-min scans for the next 50 min, and 10-min scans for the re mainder of the study. The final resolution of the recon structed positron CT images in this study was 15.6 mm full width at half maximum.
Blood sampling from a radial artery was performed for the measurement of 68Ga plasma concentrations as a function of time [ep(t)]. Tw o-milliliter samples were with drawn as rapidly as possible (�IO-s intervals) for the first 2-3 min and at progressively lengthening intervals there after. Approximately 25-30 samples were obtained in each study. The samples were centrifuged, and plasma counting was performed in an NaI well counter on 0.5ml plasma samples obtained with a calibrated pipet. In some subjects, arterial sampling was performed for the first 10-30 min of the study, and the remainder of the blood samples was obtained from a vein in a hand heated to 44°C to "arterialize" the venous blood. The sampling and counting routines were similar to those in a positron CT [18p]fluorodeoxyglucose kinetic study (Phelps et a!., 1979a; Huang et a!., 1980) . e150 studies. The procedure for measuring CBV was similar to that described by Phelps et al. (l979b) . After inhalation of 20-40 mCi C I 50, three 90-s images were acquired in the same scanning mode employed for the [68Ga]EDTA studies. Serial I-ml blood samples (� I 0 per study) were drawn from a radial artery (the same sam pling site as in the [68GaJEDTA study performed imme diately afterward) or from a venous sampling site. Arte rial blood samples are not necessary for the determination of CBV. A multiexponential fit to the whole blood con centration data was applied, and the concentrations in the blood of 150 (eb) at the midscan time of the second and third images in conjunction with tissue concentration data for 150 from these images were used for determination of absolute CBV (Eq. 9). Between 15 and 30 min after the C I SO inhalation (�7-15 half-lives of 150), the [68Ga]EDTA study was begun. Of the 12 patients reported in this study, 3 (for a total of four studies) underwent both C I SO and [68Ga]EDTA studies, whereas the remainder had only [68Ga]EDTA studies.
Patient selection
The study group comprised 12 patients with docu mented primary or metastatic brain tumors. Two patients (nos. 4 and 10) underwent a repeat [69Ga]EDTA study. The initial study in patient no. 4 is not reported here because it demonstrated an equivocal abnormality in the [68Ga]EDTA study. Three patients (nos. 10, II, and 12) had C I SO studies immediately prior to their [68Ga]EDTA studies. Patient no. 10 had clinical and X-ray CT evidence of progression of disease (metastatic melanoma) in the interval between her two studies (both paired C150/ [68Ga]EDTA studies). See Ta ble 1 for a list of the histo logical results in each patient as well as the model param eters. Figure 1 is a set of representative images from patient no. 9 with metastatic breast carcinoma in volving the left cerebellar hemisphere. The round metastatic lesion is clearly defined; the uptake in the lesion relative to vascular structures and facial and scalp activity (outside the BBB) increased with time. A circular region of interest drawn around the lesion and reproduced on each image of the study resulted in the time-activity relationship of tissue activity concentration in the lesion shown in Fig. 2 . The smooth line through the data points in Fig. 2 represents the model fit to the data.
RESULTS
Rate constants and relative CBV values
Ta ble I lists values for the rate constants K, and k2' the ratio K,/k2 (the distribution volume of l68Ga]EDTA), as weB as values for Vr of the tumors in each subject. Whenever possible, homologous re gions of interest (for determination of K" k2, and Vr using Eq. 6) were constructed by duplicating the tumor region of interest in the contralateral hemi sphere. In those cases with masses near the midline for which no truly homologous region could be drawn without including activity from the tumor, a region of the same size in apparently normal adja cent brain tissue was used. Most of the subjects had only one identifiable lesion, although subject nos. 5 and 9 had two and subject no. 10 had two on an initial study and three on a follow-up study. In each case, regions of interest were drawn over what ap peared to be representative locations of the BBB defect. Most of the lesions evidenced little internal structure on the [68Ga]EDTA images. In those masses that revealed a more complex shape, a re gion was chosen over what appeared to represent clearly identifiable and abnormal tissues throughout the sequence of images. Scalp or facial structures (areas outside the BBB that normally are charac- Fig. 1 . The data points are decay-corrected values from region-of-in terest analysis of the images in Fig. 1; the curve is the model fit to the data. In this tumor, K 1 = 0.0028 mllmin/g; k2 = 0.0238 min -1 ; Vr = 2.02 (see the text for description of the variables). The ordinate values refer to counts/min/g x 10-3 in the region of interest. Figure 3 is a plot of the relative CBV in seven lesions in three subjects (nos. 10, 11, and 12) de termined with e l So and [68Ga]EDTA. The straight line represents a linear regression fit of the data; this yielded a y-intercept of -0.16, a slope of 1.4, and a correlation coefficient of 0.97. The last point in the far right of the plot represents lesion no. 1, patient no. 10, study no. 2. On that examination it was quite close to the confluence of dural sinuses (the same lesion in study no. 1 was cut at a slightly different level). The tissue curve [Ci(t)] thus could be contaminated by extraneous counts from the sinus. If this point is neglected, linear regression yielded a slope of 1.01 (near unity), a y-intercept of 0.14, and a correlation coefficient of 0.94.
Absolute CBV estimates
As described in Materials and Methods, eBV in units of mill 00 g can be estimated from the [68Ga]EDTA kinetic data using Eqs. 7 and 8. The average CBV in the seven lesions studied with both [68Ga]EDTA and e l So was 3.50 ± 1.51 mlllOO g determined with elSo and 3.38 ± 1.52 mill 00 g with [68Ga]EDTA. There was, however, more variation between the absolute results obtained with the two methods than between the relative values discussed above. The average ratio of the absolute eBv de termined with [68Ga]EDTA to that measured with e l So in the lesions was 1.14 ± 0.71. The same ratio for the relative eBV measurements was 1.20 ± 0.17. Unidirectional transport model Patlak et aI. (1983) and Blasberg et aI. (l983a,b) developed a method for determining blood-to-brain transfer constants (K 1 ) for substances undergoing unidirectional transport from blood to brain. The method is applicable with multiple-time uptake data from tissue sampling, autoradiographically in a series of animals, or with sequential images using positron CT in a single subject. The advantages of the technique are that it is noniterative and that it verifies or disproves the assumed unidirectionality of the transport (diffusion) of a substance. The method involves plotting the ratio of the total tissue activity at time T [CP')] and the concentration of a test substance in the plasma [Cp(T)] versus the time integral of the plasma activity at time T divided by Cp(T). The slope of such a plot, if linear, is equal to K 1 • Figure 4 illustrates this approach applied to lesion no. 1 of patient no. 10 in study no. I. To calculate C;(T)/Cp(T), the original tissue data [C/t)] and plasma [68Ga]EDTA concentrations [Cp(t)] were approximated with four exponential curve fits. The original imaging and blood sampling times dif fered, and interpolated values of Cj(t) and CpCt) must be used in the above calculation. The nonlin earity of the plot indicates that the transport is not J Cereb Blood Flow Metabol, Vol. 4. No.4. 1984 unidirectional. Approximating the curve with a fifth-order polynomial, differentiating and solving for the slope at time 0 yielded a value of K I (0.0037 mllmin/g) that approximated the value obtained with the [68Ga]EDTA model (0.0049 mllmin/g). A simple linear approximation to the curve resulted in a substantial underestimation of K 1 •
DISCUSSION
Rate constants and relative CBV values
Although no prior values for transfer constants have as yet been published for human brain tumors using l68Ga]EDTA, the values of K I are higher than obtained in normal rat brain with diethylenetria mine pentaacetate (DTPA), and lower than obtained in rat brain tumors with a-aminobutyric acid (AlB), a small neutral amino acid that slowly crosses the intact BBB and is then taken up and concentrated by brain cells. Prior studies in normal rat brain pro duced K I values of � 1-3 x 10-5 mllmin/g for DTPA, �20 x 10-5 mllmin/g for EDTA, and � 1-2 x 10-3 mllmin/g for AlB (Blasberg et aI., 1983a) . Our average value of K I (2. 9 x 10-3 mllmin/g) for EDTA is thus not unexpectedly smaller than K 1 values in rat tumors of �2 x 10 -2 mllmin/g for AlB (Blasberg et ai. , 1981) . Additionally, there are phys iological reasons to expect differences between human brain and experimental rat tumors, including species differences in capillary surface areas and tumor heterogeneity. The average ratio of K l lk 2 (the distribution volume of [68Ga]EDTA) of 0. 108 ± 0. 062 mIlg is reasonably close to the extracellular space of the brain (�0. 15 mIlg) (Pardridge, 1983) . Because EDTA is an extracellular indicator, this similarity is not surprising. A ratio of K/k 2 differing significantly from 0. 15 mIlg could be explained by alterations in the extracellular space of tumors as well as by tissue edema. Additionally, the patients in this study were characterized by heterogeneities in the histology of the lesions, in treatment, and in drug regimens (i. e., X-ray therapy and steroids as well as surgical intervention). These clinical perturba tions could affect not only the ratio of Kllk 2 but also the value of the rate constants individually, since variable states of BBB permeability or types of vas cular membranes are present in these tissues.
As originally shown by Renkin (1959) and Crone (1963) and modified by Fenstermacher et aI. (1981) , the capillary permeability surface area product (P S) Patlak et al. (1983) and Blasberg et al. (1983a,b) unidirectional transport model applied to lesion no. 1, patient no. 10, study no. 1. The y-axis represents the ratio of C;(t) and Cp(t) evaluated at time T; the x axis represents the time integral of Cp(t) from o to T, divided by Cp(T) (see the text for de scription of the variables). The values of T ranged from 0 to 120 min (the duration of the experiment). As described in Materials and Methods, the original data for C;(t) and Cp(t)
were fitted with a four-exponential curve. This was necessary to calculate the ordinate and abscissa coordinates for each point on the curve. 
Vf is a unitless term representing the fraction of blood involved in diffusion from blood to brain and equals 1 -Hct for the plasma label [68Ga]EDT A.
If K/FVf is much less than 1.0 (i.e., < 0. 1), K I ap proximates PS, as can be shown by a Taylor series expansion of Eq. 9. Although flow was not mea sured explicitly in this study, average cerebral blood flow values of �0.5 ml/min/g in humans indicate that K/FVf is probably low enough such that K I approximates PS (i.e. , K/FVf < 0.1). In markedly hypovascular lesions, this approximation may not, of course, be valid. Further studies measuring flow explicitly in tumors together with K I will clarify this Issue.
The consistency of the estimates of K I and k2 obtained with Eq. 6 and 7 is illustrated in Table 2 . This consistency supports the validity of the model configuration and the physiologic significance of K I and k2• Validation of relative and absolute CBV estimates Figure 3 demonstrates that the relationship be tween the relative CBV determined by [68Ga]EDT A and C I 50 is linear and reasonably close to the line of identity. Whereas the ratios of absolute and rel ative CBY estimates determined by [68Ga]EDT A to those determined by CI50 (1.14 ± 0.71 and 1.20 ± 0.17, respectively) were not significantly different from 1.0, the relatively high standard deviation of the absolute ratio indicates that the absolute mea surements were more variable between the two 160 180 methods than the relative measurements. Possible reasons for this include variations in the term of the denominator of Eq. 9. Specifically, the values of the calibration factor (cal) between tomographic and blood data or the blood counts themselves (Cb) could contain significant errors. Although the tech nique of CBY measurement with labeled CO (using ll e) has been well validated (Phelps et aI., 1979b) , the shorter half-life of ISO compared with II C (2 and 20 min, respectively) makes any errors in the counting of ISO samples more significant than with l I e. The calibration factor was measured using 68Ga
as the source sample for scanning in the tomograph and counting in the well counter. 1 8F is a better isotope for calibrating I SO studies because both I SO and ISF are pure positron emitters. Logistical con siderations, however, mandated the use of 68Ga as a calibration source in this study. Another source of error in the absolute CBY estimates could be the measured peripheral hematocrits used in Eq. 8. These values were directly measured on the day of the study in two of the four subjects in this group, whereas in the other two subjects, the hematocrit values were obtained from the clinical laboratory together with complete blood count studies per formed within 2 weeks of the positron CT study. Although no blood loss was known to occur in this interval, the values nevertheless could have changed.
A central hematocrit differing from the 85% value of the peripheral hematocrit could also affect esti mates of CBY obtained with Eq. 8 and 9. However, unless the central/peripheral hematocrit ratio differs in individuals, this is unlikely to explain the larger variance in absolute compared with relative CBV estimates found here. A different hematocrit in tumor and normal brain regions could also affect the results. The good correlation between relative CBV values determined with Cl50 and [68Ga]EDTA (Fig. 3) , however, supports our assumption of equal hematocrits in tumor and normal brain regions in this patient group.
Unidirectional transport model
As shown by Fig. 4 , the graphical approach of Patlak et al. (1983) and Blasberg et al. (l983a, b) indicates that the transport of [68Ga]EDTA in tu mors is unlikely to be unidirectional over the du ration of this study and that a linear fit of the graph ical data produces an underestimation of the transfer constant (Kl). This result is expected if a significant back flux component is neglected and supports the requirement of a model with bidirec tional transport.
CONCLUSIONS
With [68Ga]EDTA it is possible to obtain quanti tative information about the degree of disruption of the human BBB in vivo. The estimates of K l (the transfer constant), k2 (the rate constant for brain to-blood diffusion), K/k2 (the distribution volume), and the relative and absolute CBV values obtained with the method are within the physiological range. The heterogeneity of human brain tumors examined in this study (particularly metastatic tumors that constituted the bulk of this series) allowed exami nations of the method in a range of BBB permea bilities. Results in the single patient who was studied twice in this series (patient no. 10) demon strate the potential of the technique to numerically describe changes in BBB permeability as well as to characterize the progression of disease. In the in terval between her two studies, this patient had clinically deteriorated and had undergone radiation therapy. Lesion no. 3 ( Table 1) was not evident on the first examination.
The technique may be applicable to clinical sit uations such as chemotherapy for CN S tumors when quantitative estimates of BBB permeability may help to optimize treatment (Blasberg et aI. , 1980; Neuwelt et aI., 1983) . In general, it provides a quantitative approach for examining many dif ferent cerebral disorders including selective neuro toxicity and early alterations in capillary mem branes.
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